Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-12-23
1988-10-25
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514826, A61K 3140
Patent
active
047804769
ABSTRACT:
The present invention is concerned with the use of azoniaspironortropanol esters of the general formula: ##STR1## wherein R signifies one of the following radicals: (a) an alkylene radical of the general formula: ##STR2## in which R.sub.3 is a hydrogen atom or an alkyl, benzyl, aryl or alkoxy radical and n is a whole number of from 1 to 4,
REFERENCES:
Lux et al, Chemical Abstracts, 90:48605m, 1979.
Keighley, Ann. Int. Med 65(5): 985-995 (Nov. 1966).
Speizer, et al, Brit. J. Med 1: 335-339 (Feb. 10, 1968).
Van Rossum et al., Arch. Int. Pharmacodyn. 143 (3-4): 299-330 (1963).
Grimminger Wolf
Odenthal Karl P.
Madaus GmbH & Co.
Schenkman Leonard
LandOfFree
Azoniaspironortropanol esters as asthma therapeutics and broncho does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azoniaspironortropanol esters as asthma therapeutics and broncho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azoniaspironortropanol esters as asthma therapeutics and broncho will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2269760